SCIENTIFIC STUDIES | LIPOSHAPER®
1 | MODERATE OBESITY TAKES YEARS OFF LIFE EXPECTANCY | University of Oxford, UK
The Research Department of Oxford University, UK, has released a mega global study that links abdominal fat with heart attacks, supported by 57 other studies carried out in Europe and North America, which involved almost 1 million people from all over the world over 15 years. One of the conclusions of this very important study is that moderate obesity takes around 3 years off life expectancy and severe obesity 10 years.
2 | PHOTOBIOMODULATION IN WEIGHT LOSS | Journal of Obesity & Weight Loss Therapy
This important study about the direct relation between abdominal fat and cardiovascular diseases, published by the European Society of Cardiology, points out that: “It was possible to observe that using only aerobic exercise there was a reduction of 4.3kgs of fat and 2.5cm2 of visceral fat. However, when photobiomodelling (LLLT) – the technology used on LIPOSHAPER from CLÍNICADOTEMPO – was added, the reduction was much more significant, resulting in a loss of 8.2 kg of fat and 128.6 cm2 of visceral fat.”
3 | BELLY FAT LINKED WITH HEART ATTACKS | European Society of Cardiology
A study published in the European Journal of Preventive Cardiology of the European Society of Cardiology, by Dr. Hanieh Mohammadi of the Karolinska Institute in Stockholm, Sweden, highlights the direct relationship between excess abdominal fat and increased risk of stroke, considering that excess abdominal fat is even more relevant to the risk of stroke than obesity itself. He also pointed out that reducing excess abdominal fat is more effective at preventing the risk of stroke than any medication.
4 | LOW-LEVEL LASER THERAPY FOR WEIGHT REDUTION | Mayo Clinic, USA
The study on the action of “Low-Level Laser Therapy for fat reduction” demonstrates the effectiveness of LLLT technology in reducing abdominal perimeter and the percentage of fat in the body. The lasers referred to in this study – 532nm and 635nm – are the same lasers used in CLÍNICADOTEMPO‘s LIPOSHAPER treatment to reduce abdominal perimeter and all excess fat in the body, reducing the risk of cardiovascular disease and premature death.
This study was carried out and validated by the renowned MAYO CLINIC USA, one of the three most prestigious medical clinics in the world.
The study refers to the approval of this type of laser (LLLT) by the FDA (K123237) as “effective and totally safe for the reduction of fat in the abdomen, hip and thighs.”
5 | ABDOMINAL OBESITY AND ITS ASSOCIATION WITH CARDIOVASCULAR DISEASE | European Association of Preventive Cardiology
A study published by the European Association of Preventive Cardiology has proven a direct link between excess abdominal fat and myocardial infarction. The study included 22,882 patients from Sweden.